The results were consistent with the preliminary results Eli Lilly shared in January, which disappointed investors.

Eli Lilly reported mixed results for the fourth quarter, even as demand for its blockbuster weight loss drug Zepbound and diabetes treatment ... and regulate their blood sugar.

Semaglutide and tirzepatide are medications used to manage type 2 diabetes and aid in weight loss, both belonging to a class of drugs that mimic certain hormones (GLP-1) involved in blood sugar ...

For people with diabetes, blood sugar monitoring is one of the most important ways to maintain a healthy lifestyle. A continuous glucose monitor (CGM) is the most convenient option for replacing ...

Diabetes is a condition when your blood sugar levels tend to remain high. This happens when the pancreas doesn't produce enough insulin or the body cannot effectively use the insulin that is released.